Ascenta Therapeutics, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-05. The offering totals $15.0M, of which $1.8M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Louis Bock | Director | Georgetown, TX |
| Marc Lippman | Director | Boston, MA |
| Michael Powell | Director | Cambridge, MA |
| Norman Selby | Director | New York, NY |
| Andrew E Senyei | Director | San Diego, CA |
| J. Mel Sorensen | Director | Malvern, PA |
| Joel Sussman | Director | Malvern, PA |
| Eckard E Weber | Director | San Diego, CA |
| Michael Powell | Executive Officer | Cambridge, MA |
| J. Mel Sorensen | Executive Officer | Malvern, PA |
| Joel Sussman | Executive Officer | Malvern, PA |